Mangoceuticals (MGRX) Financials: Revenue & Earnings
MGRX$0.25+0.00 +0.24%
$5.52M
Market Cap
-0.21
P/E
—
Forward P/E
24
Score
Mangoceuticals (MGRX) Financials: Revenue & Earnings
MGRX price $0.25 +0.00 +0.24%
- Ticker
- MGRX
- Price
- $0.25
- Change
- +0.00 +0.24%
- Market cap ?
- $5.52M
- P/E ?
- -0.21
- Dividend yield ?
- 0.00%
- Beta ?
- 1.98
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Stocklytics score
- 24
- Value
- 58
- Quality
- 14
- Growth
- 0
Stocklytics score rationale: value 58, quality 14, growth 0.
Financials
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 8939 | 731493 | 615873 | 456021 |
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its…
Fair value
MGRX fair value Not meaningful. Price $0.25.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-08-13 | -0.09 | — | 68.76K | — |
| 2026-05-19 | -0.22 | — | 67.86K | — |
| 2026-04-01 | 0.13 | — | 94.36K | — |
| 2025-11-14 | -0.69 | — | 84.25K | — |
| 2025-08-14 | -0.57 | — | 168.11K | — |
| 2025-05-15 | -1.29 | — | 109.31K | — |
| 2025-03-20 | -1.01 | — | 105.25K | — |
| 2024-11-14 | -0.99 | — | 133.37K | — |
| 2024-08-14 | -1.35 | — | 163.16K | — |
| 2024-05-15 | -1.50 | — | 214.09K | — |
| 2024-04-01 | -1.95 | — | 244.37K | — |
| 2023-10-27 | -1.65 | — | 245.16K | — |
| 2023-07-28 | -0.14 | — | 141.24K | — |
| 2023-05-09 | -3.41 | — | 100.72K | — |
| 2022-12-31 | -0.76 | — | 8.94K | — |
| 2022-09-30 | -1.00 | — | — | — |
| 2022-06-30 | -0.33 | — | — | — |
| 2022-03-31 | -0.02 | — | — | — |
| 2021-12-31 | -0.02 | — | — | — |
Dividends
Yield 0.00%. Payout ratio —. Frequency —.
Safety score 24/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Cohen Jacob D. | Buy | 2.00M | — | — |
| 2026-08-11 | Cohen Jacob D. | Sell | 2.00M | — | — |
| 2026-07-28 | Cohen Jacob D. | Buy | 2.00M | — | — |
| 2026-07-28 | JOHNSTON EUGENE M | Buy | 100.00K | — | — |
| 2026-07-28 | Hamilton Alex P. | Buy | 100.00K | — | — |
| 2026-03-16 | Cohen Jacob D. | Buy | 2.00M | $0.45 | 900.00K |
| 2026-03-16 | Cohen Jacob D. | Buy | 83.33K | $0.45 | 37.50K |
| 2026-03-16 | Cohen Jacob D. | Buy | 50.00K | $0.45 | 22.50K |
| 2026-03-16 | Cohen Jacob D. | Sell | 83.33K | $4.80 | 400.00K |
| 2026-03-16 | Cohen Jacob D. | Sell | 2.00M | $2.30 | 4.60M |
| 2026-03-16 | Cohen Jacob D. | Sell | 50.00K | $16.50 | 825.00K |
| 2025-12-19 | Cohen Jacob D. | Sell | 0 | $1.78 | 0 |
| 2025-12-15 | JOHNSTON EUGENE M | Sell | 3.33K | $1.17 | 3.88K |
| 2025-12-09 | JOHNSTON EUGENE M | Sell | 5.00K | $1.20 | 5.97K |
| 2025-12-05 | JOHNSTON EUGENE M | Sell | 10.00K | $1.13 | 11.28K |
| 2025-11-19 | Hamilton Alex P. | Sell | 125.00K | $1.22 | 152.88K |
| 2025-09-30 | Cohen Jacob D. | Buy | 500.00K | — | — |
| 2025-09-09 | Cohen Jacob D. | Buy | 2.00M | $2.30 | 4.60M |
| 2025-09-09 | Cohen Jacob D. | Buy | 500.00K | — | — |
| 2025-09-09 | JOHNSTON EUGENE M | Buy | 100.00K | — | — |
| 2025-09-09 | D'Alessio Lorraine Pamela | Buy | 100.00K | — | — |
| 2025-09-09 | Hamilton Alex P. | Buy | 100.00K | — | — |
| 2025-09-09 | MYERS KENNY | Buy | 100.00K | — | — |
| 2025-07-21 | Cohen Jacob D. | Buy | 50.00K | $1.85 | 92.50K |
| 2025-07-21 | Cohen Jacob D. | Buy | 0 | $1.78 | 0 |
| 2025-06-05 | Cohen Jacob D. | Buy | 200.00K | — | — |
| 2025-06-05 | Cohen Jacob D. | Sell | 200.00K | — | — |
| 2025-04-10 | Cohen Jacob D. | Buy | 200.00K | — | — |
| 2025-01-14 | Isaac Antonios | Other | 0 | — | — |
| 2024-11-11 | JOHNSTON EUGENE M | Buy | 25.00K | — | — |
| 2024-08-26 | Cohen Jacob D. | Buy | 800.00K | — | — |
| 2024-08-26 | Cohen Jacob D. | Sell | 800.00K | — | — |
| 2024-06-26 | Hamilton Alex P. | Sell | 108.43K | $0.32 | 34.70K |
| 2024-06-25 | Hamilton Alex P. | Sell | 16.57K | $0.31 | 5.14K |
| 2024-06-03 | Hammer Amanda Elizabeth | Buy | 100.00K | — | — |
| 2024-06-03 | Hamilton Alex P. | Buy | 100.00K | — | — |
| 2024-06-03 | MYERS KENNY | Buy | 100.00K | — | — |
| 2024-06-03 | Cohen Jacob D. | Buy | 800.00K | — | — |
| 2024-06-03 | D'Alessio Lorraine Pamela | Buy | 100.00K | — | — |
| 2023-12-28 | Cohen Jacob D. | Buy | 125.00K | $0.32 | 40.00K |
| 2023-10-03 | JOHNSTON EUGENE M | Buy | 50.00K | — | — |
| 2023-05-01 | Hammer Amanda Elizabeth | Buy | 150.00K | $1.10 | 165.00K |
| 2023-05-01 | Hammer Amanda Elizabeth | Buy | 75.00K | — | — |
| 2023-05-01 | Hammer Amanda Elizabeth | Other | 0 | — | — |
| 2023-04-10 | Cohen Jacob D. | Buy | 275.00K | $1.00 | 275.00K |
| 2023-04-04 | Cohen Jacob D. | Buy | 8.00M | — | — |
| 2023-04-04 | Cohen Jacob D. | Sell | 8.00M | — | — |
| 2023-03-20 | Hamilton Alex P. | Other | 0 | — | — |
| 2023-03-20 | Arango Jonathan | Other | 0 | — | — |
| 2023-03-20 | Arango Jonathan | Other | 500.00K | $1.10 | 550.00K |
| 2023-03-20 | JOHNSTON EUGENE M | Other | 0 | — | — |
| 2023-03-20 | MYERS KENNY | Other | 0 | — | — |
| 2023-03-20 | D'Alessio Lorraine Pamela | Other | 0 | — | — |
| 2023-03-20 | Cohen Jacob D. | Other | 0 | — | — |
| 2023-03-20 | Cohen Jacob D. | Sell | 750.00K | $1.10 | 825.00K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 19, holders +1 vs prior quarter. Ownership 7.05%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 338.96K | 338.96K | New | 128.81K |
| XTX TOPCO LTD | 186.26K | 173.11K | +1317.26% | 70.78K |
| GEODE CAPITAL MANAGEMENT, LLC | 156.24K | -38.24K | -19.66% | 59.37K |
| IKARIAN CAPITAL, LLC | 138.15K | 0 | 0.00% | 52.50K |
| VANGUARD CAPITAL MANAGEMENT LLC | 123.04K | 0 | 0.00% | 46.76K |
| VANGUARD FIDUCIARY TRUST CO | 57.16K | 0 | 0.00% | 21.72K |
| BOOTHBAY FUND MANAGEMENT, LLC | 38.44K | 0 | 0.00% | 14.61K |
| NORTHERN TRUST CORP | 37.58K | 0 | 0.00% | 14.28K |
| ACKERMAN CAPITAL ADVISORS, LLC | 34.50K | 0 | 0.00% | 13.11K |
| HRT FINANCIAL LP | 36.00K | 36.00K | New | 13.00K |
| ACT ADVISORS, LLC. | 26.86K | 26.86K | New | 10.21K |
| GOLDMAN SACHS GROUP INC | 11.59K | -168 | -1.43% | 4.40K |
| CSENGE ADVISORY GROUP | 10.00K | 0 | 0.00% | 3.80K |
| MERCER GLOBAL ADVISORS INC /ADV | 6.67K | 6.67K | New | 2.53K |
| AMERIFLEX GROUP, INC. | 2.88K | 2.88K | New | 1.10K |
| FORTITUDE FAMILY OFFICE, LLC | 1.34K | 0 | 0.00% | 510 |
| MORGAN STANLEY | 1.00K | 0 | 0.00% | 380 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 783 | -2 | -0.25% | 298 |
| BARCLAYS PLC | 5 | 5 | New | 2 |
| OSAIC HOLDINGS, INC. | 0 | -3.29K | -100.00% | 0 |
| JANE STREET GROUP, LLC | 0 | -72.75K | -100.00% | 0 |
| VIRTU FINANCIAL LLC | 0 | -61.03K | -100.00% | 0 |
| STONEX GROUP INC. | 0 | -16.04K | -100.00% | 0 |
Earnings and financials
Mangoceuticals, Inc. (MGRX) trades at $0.25, with a market cap of $5.52M and a trailing P/E of -0.21. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 8939 | 731493 | 615873 | 456021 |
Insights · Dividends · Forecast · Financials · Learn